Reported Reactions

Devices › Ventilator, continuous, non-life-supporting

Device brand name · Ventilator continuous non-life-supporting

BiPAP AVAPS: medical device reports filed with FDA

388 reports name it, 2022–2026. Manufacturer given most often on reports: Respironics. Product code MNS.

388
device reports naming the brand
0% of all MAUDE reports · about 88 a year
273
reports, 12 months to August 2026
15 in the 12 months before
97.7%
classified as malfunction
86% across the product code
0.3%
classified as death, as reported
1 reports · not verified by FDA

FDA's MAUDE database holds 388 reports that name the brand "BiPAP AVAPS" (ventilator continuous non-life-supporting), received between February 2022 and August 2026; the manufacturer given most often on reports is Respironics. Spellings of one product vary from report to report.

273 reports arrived in the 12 months to August 2026, up 1720% from 15 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (97.7%), injury (2.1%) and death (0.3%); across all ventilator, continuous, non-life-supporting reports (product code MNS) death is recorded in 3.4% and malfunction in 86%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are degraded (91.8%), thermal decomposition of device (5.2%) and excessive heating (0.5%). The patient problems coded most often are headache, cancer and dizziness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

04691Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 4Mar 2022: 43Apr 2022: 3May 2022: 1Jun 2022: 6Jul 2022: 1Aug 2022: 3Sep 2022: 2Oct 2022: 2Nov 2022: 3Dec 2022: 02023Jan 2023: 2Feb 2023: 1Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 1Sep 2023: 0Oct 2023: 1Nov 2023: 1Dec 2023: 02024Jan 2024: 1Feb 2024: 1Mar 2024: 0Apr 2024: 3May 2024: 0Jun 2024: 0Jul 2024: 6Aug 2024: 15Sep 2024: 2Oct 2024: 2Nov 2024: 0Dec 2024: 12025Jan 2025: 0Feb 2025: 0Mar 2025: 1Apr 2025: 3May 2025: 0Jun 2025: 2Jul 2025: 0Aug 2025: 4Sep 2025: 0Oct 2025: 0Nov 2025: 1Dec 2025: 52026Jan 2026: 25Feb 2026: 91Mar 2026: 24Apr 2026: 0May 2026: 9Jun 2026: 49Jul 2026: 67Aug 2026: 2

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01342672022: 6820222023: 620232024: 3120242025: 1620252026: 2672026

Event type and report source

Event type, as classified on the report

Death0.3%1
Injury2.1%8
Malfunction97.7%379
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%388
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 11,458 reports carrying product code MNS. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Degraded35691.8%78.7%
Thermal decomposition of device205.2%0.5%
Excessive heating20.5%0.1%
Overheating of device20.5%0.5%
Electrical /electronic property probleman electrical or electronic problem10.3%9.9%
Excess flow or over-infusion10.3%0%
Mechanical problema mechanical problem10.3%0.1%
Temperature problem10.3%0.1%
Unexpected shutdown10.3%0.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Headachehead pain71.8%
Cancer51.3%
Dizzinesslight-headedness or unsteadiness41%
Coughcough20.5%
Dyspneashortness of breath20.5%
Sore throat20.5%
Chest painchest pain10.3%
Chronic obstructive pulmonary disease (COPD)10.3%
Eye irritationeye irritation10.3%
Hypersensitivity/allergic reaction10.3%
Liver damage/dysfunction10.3%
Lymphomaa cancer of the lymphatic system10.3%
Nauseafeeling sick10.3%
Respiratory arrestbreathing stopped10.3%
Skin inflammation/ irritation10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBiPAP AVAPSProduct code MNSAll MAUDE reports
Reports38811,45826,136,888
Share of that pool—3.4%0%
Classified as death, per 1,000 reports3349
Classified as injury2.1%10.4%36.2%
Classified as malfunction97.7%86%62.3%
Filed by the manufacturer100%98.9%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code MNS

BrandReportsLatest 12 monthsClassified as death
DreamStation BiPAP autoSV2,7251041.5%
BiPAP A301,8471,5650.2%
BiPAP autoSV ADV1,0391762.4%
DreamStation BiPAP ST30682261.3%
Bipap Focus Noninvasive Ventilator System38201%
BiPAP A30, Germany3433430%
BiPAP AVAPS C Series3312370.9%
Dreamstation Bipap St23700.4%
DreamStation BiPAP AVAPS216230.9%
Bipap S/T C Series230963.5%
Dreamstation Bipap Avaps3022083.6%
BiPAP A30-S, Germany1781780%
BiPAP autoSV209841.4%
Dreamstation Bipap33741.5%
Respironics17,6932,2390.3%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BiPAP AVAPS reports

How many FDA reports name BiPAP AVAPS?

388 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 273 in the latest 12 months.

What kinds of events are reported?

malfunction (97.7%), injury (2.1%) and death (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

degraded (91.8%), thermal decomposition of device (5.2%), excessive heating (0.5%), overheating of device (0.5%) and electrical /electronic property problem (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BiPAP AVAPS was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.